Fernandes and Chowdhury
JOCNote
2997, 2926, 2831, 1752, 1479, 1355, 1273, 1214, 1167, 1139, 1100,
the natural product appears at δ 5.70 ppm in the 1H NMR.2
The synthetic syn-stereoisomers (2b and ent-2b) had the C-2
proton appearing at δ 6.05 ppm, while the anti-stereoisomers
(2a and ent-2a) had the same proton at δ 5.69 ppm.13 From
this observation, we believe the natural isolate to be the anti-
stereoisomer (relative configuration) and should have either
(2R,3R) or (2S,3S) absolute configurations. Due to a large
difference in optical rotation value of synthetic (-115.7 for
2a and þ109.8 for ent-2a) in comparison to natural isolate
(-2.2), we could not make the assignment of absolute
configuration unambiguously to the natural phenatic acid
B at this stage. Also, the natural isolate was not available for
further studies.
In summary, we have achieved the first total syntheses of
all stereoisomers of phenatic acid B. The synthetic strategy is
based on an efficient combination of the Sharpless asym-
metric dihydroxylation, Johnson-Claisen rearrangement,
and hydroboration-oxidation as the key steps. The syn-
thesis of phenatic acid B stereoisomers is completed in
high enantio- and diastereoselectivity in 11-12 steps and
overall yield of 5-8%. We have also established the absolute
configurations of all stereoisomers of phenatic acid B.
The naturally isolated product is an anti-stereoisomer,
while the absolute stereochemistry could be (2R,3R) or
(2S,3S). The synthetic strategy is flexible and will poten-
tially allow us to synthesize the other members of the
phenatic acid family (Figure 1). Work in this direction is in
progress.
1
1041, 1009, 876, 794, 667 cm-1; H NMR (400 MHz, CDCl3/
TMS) δ = 7.04 (s, 1H), 6.95 (s, 1H), 5.5-5.6 (m, 1H), 4.98-5.04
(m, 3H), 4.38 (dd, J = 7.6, 4.2 Hz, 1H), 3.75 (s, 3H), 3.18-3.23
(m, 1H), 2.97 (br s, 1H, OH), 2.79 (dd, J = 17.2, 9.5 Hz, 1H),
2.45 (dd, J = 17.2, 9.5 Hz, 1H), 2.27 (s, 3H), 2.26 (s, 3H); 13
C
NMR (100 MHz, CDCl3) δ = 175.7, 153.8, 135.8, 133.7, 132.1,
131.3, 130.7, 125.7, 117.3, 87.5, 69.5, 61.0, 41.2, 35.0, 20.8, 16.1;
HRMS (ESIþ) calcd for [C16H20O4 þ Na]þ 299.1259, found
299.1252.
[(2R,3R)-2-(2-Hydroxy-3,5-dimethylbenzoyl)-5-oxotetrahy-
drofuran-3-yl]acetic acid (Phenatic Acid B, 2a): To a solution of
17 (0.13 g, 0.42 mmol) in dry CH2Cl2 (5 mL) at 0 °C was added
AlCl3 (0.198 g, 1.48 mmol, 3.5 equiv) in portions, and the
reaction mixture was stirred for 15 min. The ice bath was
removed and stirring continued at room temperature for
1.5 h. It was then quenched with water (5 mL), and the solution
was extracted with CH2Cl2 (5 ꢀ 25 mL). The combined
organic layers were washed with brine, dried (Na2SO4), and
concentrated. The residue was purified by silica gel flash
column chromatography using petroleum ether/EtOAc (1:1)
as eluent to provide 2a (0.099 g, 80%) as a white solid: mp
185-187 °C; [R]25 = -115.7 (c = 0.2, MeOH); IR (KBr
D
pallet) ν = 3445, 3231, 2925, 2853, 1783, 1756, 1705, 1645,
1474, 1414, 1376, 1321, 1290, 1193, 1177, 1091, 1056, 1019,
1
919, 860, 787, 767, 702 cm-1; H NMR (400 MHz, CDCl3/
TMS) δ = 11.8 (s, 1H), 7.48 (s, 1H), 7.25 (s, 1H), 5.69 (d, J =
3.0 Hz, 1H), 3.1-3.15 (m, 1H), 2.85 (dd, J = 17.7, 8.5 Hz, 1H),
2.75 (dd, J = 17.1, 7.9 Hz, 1H), 2.64 (dd, J = 17.1, 6.7 Hz, 1H),
2.32 (dd, J = 17.7, 3.7 Hz, 1H), 2.27 (s, 3H), 2.23 (s, 3H); 13
C
NMR (100 MHz, CDCl3) δ = 198.5, 175.9, 175.2, 159.9,
140.0, 128.0, 127.7, 126.8, 115.8, 80.5, 37.0, 34.5, 33.0, 20.4,
15.4; HRMS (ESIþ) calcd for [C15H16O6 þ H]þ 293.1025,
found 293.1035.
Experimental Section
(4S,5R)-5-[(R)-Hydroxy-(2-methoxy-3,5-dimethylphenyl)methyl]-
4-vinyldihydrofuran-2(3H)-one (6a) and (4R,5R)-5-[(R)-Hydroxy-(2-
methoxy-3,5-dimethylphenyl)methyl]-4-vinyldihydrofuran-2(3H)-one
(6b): To a solution of allyl alcohol 7 (1.3 g, 4.45 mmol) in toluene (15
mL) were added trimethylorthoacetate (5.34 g, 5.6 mL, 44.46 mmol,
10 equiv) and EtCO2H (cat, 5 drops), and the solution was refluxed
for 12 h. After cooling to room temperature, the volatile material was
removed under reduced pressure and the residue was purified by
silica gel flash column chromatography using petroleum ether/
EtOAc (95:5) as eluent to provide 14 (1.36 g, 88%) as a colorless
[(2R,3S)-2-(2-Hydroxy-3,5-dimethylbenzoyl)-5-oxotetrahy-
drofuran-3-yl]acetic acid (Phenatic Acid B, 2b): The title com-
pound was prepared from 23 (0.028 g, 0.091 mmol) by a similar
procedure as described for the conversion of 17 to 2a with
AlCl3 to give 2b (0.0214 g, 80%) as white solid: mp 188-190 °C;
[R]25 = -103.3 (c = 0.3, MeOH); IR (thin film) ν = 3395,
D
3134, 2923, 2854, 1790, 1750, 1725, 1634, 1474, 1422, 1282, 1262,
1227, 1173, 1143, 1100, 1053, 1041, 978, 845, 796,
696 cm-1 1H NMR (400 MHz, CDCl3/TMS) δ = 11.9 (s,
;
1H), 7.28 (s, 1H), 7.27 (s, 1H), 6.05 (d, J = 7.9 Hz, 1H),
3.32-3.38 (m, 1H), 2.79 (dd, J = 17.4, 8.5 Hz, 1H), 2.56 (dd,
J = 17.4, 10.4 Hz, 1H), 2.38-2.41 (m, 2H), 2.26 (s, 3H), 2.24 (s,
3H); 13C NMR (100 MHz, CDCl3) δ = 199.7, 175.4, 175.2,
159.9, 140.4, 128.2, 128.1, 126.2, 116.9, 77.0, 35.4, 33.9, 32.7,
20.5, 15.4; HRMS (ESIþ) calcd for [C15H16O6 þ H]þ 293.1025,
found 293.1031.
1
oil. Analysis of crude 14 by H NMR indicated calcd 55:45 C-3
diastereomeric mixture.
To a solution of 14 (1.36 g, 3.9 mmol) in MeOH (25 mL) was
added 3 N HCl (3 mL) and stirred for 12 h at room temperature.
It was then quenched with powdered NaHCO3 (1.0 g) and
filtered. The filtrate was concentrated and the residue purified
by silica gel flash column chromatography using petroleum
ether/EtOAc (85:15) as eluent to provide 6b (0.475 g, 44%) as
white crystalline solid. Further elution gave 6a (0.57 g, 53%)
as colorless crystalline solid. Data for 6b: mp 144-146 °C;
Acknowledgment. This work was financially sponsored by
IRCC, IIT-Bombay. A.K.C. is grateful to CSIR New Delhi
for a research fellowship. We are thankful to SAIF IIT-
Bombay for X-ray facility, and Prof. H. Tomoda and co-
[R]25 = -135.7 (c = 0.14, CHCl3); IR (KBr film) ν = 3458,
D
2991, 2954, 2826, 1753, 1475, 1409, 1350, 1313, 1249, 1213, 1188,
1136, 1069, 1012, 930, 803, 672 cm-1 1H NMR (400 MHz,
;
1
workers for providing copies of H and 13C NMR of the
CDCl3/TMS) δ = 7.0 (s, 1H), 6.95 (s, 1H), 6.02-6.12 (m, 1H),
5.21-5.33 (m, 2H), 5.11-5.16 (m, 1H), 4.70 (dd, J = 8.2, 2.1 Hz,
1H), 3.75 (s, 3H), 3.28-3.37 (m, 1H), 3.01 (br s, 1H, OH), 2.84
(dd, J = 17.2, 10.2 Hz, 1H), 2.58 (dd, J = 17.4, 9.1 Hz, 1H), 2.27
(s, 3H), 2.26 (s, 3H); 13C NMR (100 MHz, CDCl3) δ = 177.0,
153.7, 134.8, 133.7, 132.0 (2C), 130.7, 126.0, 118.9, 84.8, 69.4,
61.0, 43.0, 34.4, 20.8, 16.1; HRMS (ESIþ) calcd for [C16H20O4
þ Na]þ 299.1259, found 299.1247. Data for 6a: mp 84-86 °C;
natural phenatic acid B.
Supporting Information Available: General information
and experimental procedures for preparation and compound
characterization data of 11, 9, 8, ent-8, 12, ent-12, 13, ent-13, 7,
ent-7, ent-6a, ent-6b, 16, 17, 19, 20, 21, 22, 23, ent-19, ent-21, 24,
25, ent-17, ent-23, ent-2a, and ent-2b, copies of NMR spectra for
all new compounds. Crystallographic data for compounds 6a
and 6b. This material is available free of charge via the Internet
[R]25 = -50.0 (c = 0.16, CHCl3); IR (KBr film) ν = 3429,
D
(13) See Supporting Information for a comparison.
J. Org. Chem. Vol. 74, No. 22, 2009 8829